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to Aortobronchial Fistula
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Introduction. Aortobronchial fistula is a rare but potentially fatal condition. We report our experience in the endovascular
treatment of acute haemoptysis in high risk patients with aortobronchial fistula.
Report. Between May 2002 and December 2004 five patients presenting with acute haemoptysys due to aortobronchial
fistula were treated by endovascular stent grafting of the descending thoracic aorta. We did not observe intraoperative
or perioperative mortality, stent-graft infection or paraplegia. In one case endoleak occurred.
Conclusion. Endovascular stent-grafting represents an effective therapeutic option for the management of aortobronchial
fistula. Careful follow up of the patients is mandatory.
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Aortobronchial fistula (ABF) is an uncommon disease.
If untreated, there is a mortality approaching 100%
secondary to exsanguinating haemoptysis. Early diag-
nosis and treatment are essential for survival. Open
surgical repair is associated with high morbidity and
mortality rates, ranging from 25% to 41%.1 Endovas-
cular treatment of ABF offers a less invasive treatment
option. We present five cases of ABF successfully
managed with endoluminal stent grafting.
Report
Between May 2002 and December 2004, five patients
(2 men, mean age 75.2, range 60e87 years) underwent
endovascular treatment for acute haemoptysis due to
ABF. Three patients had penetrating aortic ulcers
(PAU), one patient had a proximal anastomotic
pseudoaneurysm related to previous thoracic aortic
reconstruction, and the last patient had a primary
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patients had a history of fever, chills or productive
sputum. One patient presented with leukocytosis.
Due to associated comorbidity and previous aortic
reconstruction, open repaired was considered inap-
propriate. The ABF was demonstrated on spiral CT
scan or aortography (Fig. 1), transesophageal echocar-
diography (TEE) and bronchoscopy. All procedures
were performed under general anaesthesia, in vascu-
lar operative suites equipped with digital subtraction
angiography (DSA) and TEE. The access artery was
the common femoral artery in four and the common
iliac artery in one patient. A 90 cm-long 7F introducer
sheath was placed in the aortic arch via the contralat-
eral femoral artery for angiographic evaluation. TEE
was used to delineate the exact position of the fistula.
A stiff guide-wire was introduced via the access
vessel using a 5F sheath and, subsequently, the intro-
ducer system of endograft was advanced under fluo-
roscopic guidance. The device was deployed under
controlled hypotension. We implanted six stentgrafts:
five Medtronic Talent and one Cook Zenith tho-
racic stent-graft in the descending aorta with one pa-
tient receiving 2 stentgrafts. Broad spectrum antibiotic
therapy was administered to all patients preopera-
tively and for 3 weeks postoperatively. A follow-up
spiral CT scan and radio-labelled white cell scanrved.
367Endovascular Treatment of Acute Haemoptysiswere performed one month after surgery. TEE was
performed at 6 months. Annual spiral CT scans
were carried out from one year.
No intraoperative complications or deaths occurred.
In one patient an additional proximal stentgraft was
necessary, four days after the primary procedure, to
treat a type one endoleak. Two patients had postoper-
ative haemoptysis, which was considered to be due to
residual blood clots in the bronchial tree. Two patients
had a postoperative pneumonia and one patient had
positive blood cultures (Salmonella saprofitica). No pa-
tient had postoperative signs of sepsis (leukocytosis,
fever, elevated C-reactive protein). After amean follow
up of 26.4 months (range 12e43 months), all patients
were alive and well without recurrence of hemoptysis,
and serial spiral CT scan confirmed satisfactory place-
ment of the aortic stentgraft (Fig. 2).
Discussion
The first ABF was described by Girardet in 19142 in
a patient affected by pulmonary tubercolosis. Mycotic
aneurysms, degenerative aneurysms and postopera-
tive pseudoaneurysms represent the main causes of
ABF. In our experience, ABF was secondary to pene-
trating aortic ulcer (PAU) in 3 patients (60%). The
most frequent localization (92% of cases) of ABF is
between the descending aorta and the left bronchial
tree. The first and main symptom of ABF is intermit-
tent hemoptysis; although less frequently, massive
bleeding may manifest abruptly without warning.
Only in exceedingly rare cases is it possible to
Fig. 1. Preoperative CT scan delineates PAU of descending
thoracic aorta (DTA) and proximity to the left lower seg-
ment bronchus.visualise the ABF. A fistulous tract was rarely identi-
fied preoperatively by angiography or bronchoscopy
and this technique is hazardous, as it can dislodge
a sealing clot with fatal hemoptysis. Nevertheless,
we think that bronchoscopy is useful in the diagnostic
assessment of ABF and it should be performed with
extreme care. Contrast filling of the bronchial tree af-
ter CTA is diagnostic of ABF but only seen in approx-
imately 50% of cases. Findings suggestive of ABF on
CT include pseudoaneurysm, aortic anatomy abnor-
malities, lung parenchyma consolidation and com-
pression of bronchial tree. If not treated, ABF is
uniformly fatal. The mortality of conventional surgical
repair remains high (24%).1,3
In 1996 Chuter et al.4 reported successful treatment
of ABF with endovasular stenting. To date, 24 cases of
endovascular treatment of ABF have been reported by
12 groups of investigators.1,5 There was no mortality
associated with the procedures. Our series adds five
consecutive patients that had been treated with
satisfying results. All patients survived, and there
was no procedure-related morbidity. One potential
life-threatening complication is stent-graft infection;
however, in our experience, no signs of infections
were detected by postoperative scintigraphy with
labelled leukocytes.
In conclusion, endovascular stent-grafting provides
a safe and reliablemethod of treatment ofABF, although
additional follow-up ismandatory before this technique
is demonstrated to be effective in the long term.
Fig. 2. Spiral CT scan shows adeguate endoluminal stent-
graft placement.Eur J Vasc Endovasc Surg Vol 32, October 2006
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